Contributors |
|
ix | |
|
1 A case of 2019-nCoV novel coronavirus outbreak |
|
|
1 | (22) |
|
|
|
|
|
1 | (9) |
|
1.1.1 History of coronavirus |
|
|
3 | (2) |
|
1.1.2 Novel coronavirus-2019 |
|
|
5 | (2) |
|
1.1.3 Infectivity of COVID-19 |
|
|
7 | (1) |
|
1.1.4 Clinical symptoms and its effect |
|
|
8 | (2) |
|
1.2 Necessary precautions |
|
|
10 | (4) |
|
1.2.1 Appropriate mask and its availability |
|
|
11 | (1) |
|
1.2.2 Role of disinfectants |
|
|
12 | (1) |
|
|
12 | (2) |
|
|
14 | (3) |
|
1.3.1 Suspicious symptoms |
|
|
14 | (1) |
|
1.3.2 Available approaches for treatment |
|
|
15 | (1) |
|
1.3.3 Medical observation |
|
|
16 | (1) |
|
|
16 | (1) |
|
|
17 | (2) |
|
1.4.1 Young people and COVID-19 |
|
|
18 | (1) |
|
1.4.2 Medicines available for curing virus |
|
|
18 | (1) |
|
|
19 | (4) |
|
|
20 | (3) |
|
2 Diagnostic tools and automated decision support systems for COVID-19 |
|
|
23 | (28) |
|
|
|
23 | (1) |
|
2.2 Molecular assay-based diagnosis |
|
|
24 | (3) |
|
2.2.1 Reverse transcriptase polymerase chain reaction |
|
|
25 | (1) |
|
2.2.2 RT-PCR assay procedure |
|
|
25 | (1) |
|
2.2.3 Diagnostic precision of RT-PCR-based diagnosis |
|
|
25 | (1) |
|
2.2.4 Limitations of RT-PCR-based diagnosis |
|
|
26 | (1) |
|
|
27 | (1) |
|
2.3 Serological and immunological assay-based diagnosis |
|
|
27 | (4) |
|
2.3.1 Types of serology-based testing |
|
|
28 | (1) |
|
2.3.2 Diagnostic precision of serology-based testing |
|
|
29 | (1) |
|
2.3.3 Uses of laboratory-based assays in the context of Al and data science |
|
|
30 | (1) |
|
|
30 | (1) |
|
2.4 Chest and lung imaging-based diagnosis |
|
|
31 | (20) |
|
2.4.1 Chest X-ray imaging modality |
|
|
31 | (1) |
|
2.4.2 COVID-19 diagnosis using chest X-ray |
|
|
31 | (1) |
|
2.4.3 Computer-aided diagnosis (CAD) using chest X-ray |
|
|
32 | (5) |
|
2.4.4 Diagnostic precision of CXR-based diagnosis |
|
|
37 | (1) |
|
2.4.5 Benefits and limitations of CXR-based diagnosis |
|
|
37 | (1) |
|
2.4.6 Chest CT-scan imaging modality |
|
|
37 | (2) |
|
2.4.7 COVID-19 diagnosis using chest CT scan |
|
|
39 | (1) |
|
2.4.8 Computer-aided diagnosis using chest CT scan |
|
|
39 | (2) |
|
2.4.9 Diagnostic precision of CT-based diagnosis |
|
|
41 | (1) |
|
2.4.10 Benefits and limitations of CT-based diagnosis |
|
|
42 | (1) |
|
2.4.11 Case study: radiology observations vs. CAD |
|
|
42 | (1) |
|
2.4.12 Lung ultrasound imaging modality |
|
|
43 | (1) |
|
2.4.13 COVID-19 diagnosis using lung ultrasound |
|
|
43 | (2) |
|
|
45 | (1) |
|
|
45 | (6) |
|
|
51 | (28) |
|
|
|
|
|
51 | (1) |
|
3.2 The mathematical modeling establishment in epidemiology |
|
|
52 | (1) |
|
3.3 Mathematical modeling methodologies in epidemiology |
|
|
53 | (1) |
|
3.4 The philosophy of mathematical modeling |
|
|
54 | (5) |
|
3.4.1 Complexity of the model |
|
|
55 | (1) |
|
3.4.2 Testing of hypothesis and formulation of a model |
|
|
56 | (3) |
|
3.5 The nature of epidemiological data |
|
|
59 | (2) |
|
3.5.1 Stationary time series |
|
|
60 | (1) |
|
|
61 | (1) |
|
3.6 Microparasitic infections from childhood |
|
|
61 | (1) |
|
3.7 A simple epidemic model - COVID case studies |
|
|
62 | (10) |
|
|
62 | (1) |
|
3.7.2 The process of transmission |
|
|
62 | (1) |
|
3.7.3 Between-compartment flux of individuals |
|
|
63 | (3) |
|
3.7.4 Dynamics analysis and deterministic setup of COVID |
|
|
66 | (2) |
|
3.7.5 The average age and statistics at infection |
|
|
68 | (1) |
|
3.7.6 Data analysis vs COVID cases |
|
|
69 | (3) |
|
|
72 | (3) |
|
|
72 | (1) |
|
|
73 | (2) |
|
|
75 | (1) |
|
|
76 | (1) |
|
|
77 | (1) |
|
|
77 | (2) |
|
|
78 | (1) |
|
4 Social media sentiment analysis and emotional intelligence including women role during COVID-19 crisis |
|
|
79 | (30) |
|
|
|
|
79 | (2) |
|
|
81 | (15) |
|
4.2.1 Importance of social media |
|
|
82 | (1) |
|
4.2.2 Social media versus misleading information |
|
|
83 | (5) |
|
4.2.3 Sentiment analysis and emotional intelligence |
|
|
88 | (8) |
|
4.3 Role of women during COVID-19 pandemic |
|
|
96 | (6) |
|
4.3.1 Women care, duties, and COVID-19 |
|
|
96 | (1) |
|
4.3.2 Women duties during COVID-19 |
|
|
97 | (3) |
|
4.3.3 Principle measures and principle alternatives |
|
|
100 | (2) |
|
|
102 | (4) |
|
4.5 Result and discussion |
|
|
106 | (1) |
|
|
107 | (2) |
|
|
108 | (1) |
|
5 Role of technology in COVID-19 pandemic |
|
|
109 | (1) |
|
|
|
|
109 | (1) |
|
5.2 Technology and medical science |
|
|
110 | (1) |
|
5.2.1 Electrocardiography (EKG) |
|
|
110 | (1) |
|
|
111 | (1) |
|
|
111 | (1) |
|
|
111 | (1) |
|
5.3 Past pandemics and technology |
|
|
111 | (2) |
|
|
112 | (1) |
|
5.3.2 Electronic surveillance system |
|
|
112 | (1) |
|
5.3.3 Monitoring online search engines |
|
|
112 | (1) |
|
5.4 Use of technology during COVID-19 |
|
|
113 | (22) |
|
5.4.1 Internet of Things (IoT) and Internet of Medical Things (IoMT) |
|
|
113 | (8) |
|
|
121 | (4) |
|
|
125 | (5) |
|
5.4.4 Bluetooth and GPS technology |
|
|
130 | (3) |
|
5.4.5 Telemedicine: a new era |
|
|
133 | (2) |
|
|
135 | (1) |
|
|
135 | (1) |
|
|
135 | (4) |
|
|
136 | (3) |
|
|
139 | (24) |
|
|
|
|
|
139 | (1) |
|
6.2 Data science and its applications |
|
|
140 | (4) |
|
6.2.1 Patient prioritization to control risk |
|
|
140 | (1) |
|
6.2.2 Diagnosis and screening |
|
|
140 | (1) |
|
6.2.3 Modeling for epidemic |
|
|
141 | (1) |
|
6.2.4 Tracing the contacted people |
|
|
141 | (1) |
|
6.2.5 Acknowledging social interventions |
|
|
142 | (1) |
|
|
142 | (1) |
|
|
143 | (1) |
|
|
144 | (1) |
|
6.2.9 Other supportive datasets |
|
|
144 | (1) |
|
6.2.10 Competition database |
|
|
144 | (1) |
|
6.3 Survey on ongoing research |
|
|
144 | (6) |
|
6.3.1 Image data analysis |
|
|
145 | (1) |
|
6.3.2 Audio data analysis |
|
|
145 | (1) |
|
6.3.3 Sensor data analysis |
|
|
145 | (1) |
|
6.3.4 Drug discovery analysis |
|
|
146 | (4) |
|
6.4 Bibliometric data collection |
|
|
150 | (1) |
|
6.5 Data science and cross cutting challenges |
|
|
150 | (4) |
|
|
150 | (1) |
|
6.5.2 Exactitude of output versus urgency |
|
|
151 | (2) |
|
6.5.3 Ethics, security, and privacy |
|
|
153 | (1) |
|
6.5.4 Requirement of multidisciplinary collaboration |
|
|
153 | (1) |
|
6.5.5 Latest data modalities |
|
|
154 | (1) |
|
6.5.6 Results for the developing world |
|
|
154 | (1) |
|
|
154 | (9) |
|
|
155 | (8) |
Index |
|
163 | |